Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00449
|
|||||
| Drug Name |
Hydroxychloroquine
|
|||||
| Synonyms |
2-((4-((7-Chloro-4-quinolyl)amino)pentyl)ethylamino)ethanol; 2-(N-(4-(7-Chlor-4-chinolylamino)-4-methylbutyl)ethylamino)ethanol; 2-[4-[(7-chloroquinolin-4-yl)amino]pentyl-ethylamino]ethanol; 2-[{4-[(7-chloroquinolin-4-yl)amino]pentyl}(ethyl)amino]ethanol; 7-Chloro-4-(4-(N-ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino)quinoline; 7-Chloro-4-(4-(ethyl(2-hydroxyethyl)amino)-1-methylbutylamino)quinoline; 7-Chloro-4-(5-(N-ethyl-N-2-hydroxyethylamino)-2-pentyl)aminoquinoline; Gen-Hydroxychloroquine 200mg Tablets; HCQ; Hidroxicloroquina; Hidroxicloroquina [INN-Spanish]; Hydroxychlorochin; Hydroxychloroguine; Hydroxychloroquine (INN);Hydroxychloroquine [INN:BAN]; Hydroxychloroquine Sulfate (1:1) Salt; Hydroxychloroquinum; Hydroxychloroquinum [INN-Latin]; Idrossiclorochina; Idrossiclorochina [DCIT]; Oxichlorochinum; Oxichloroquine; Oxychlorochin; Oxychloroquine; Plaquenil (TN); Polirreumin; Polirreumin (TN); Quensyl; WIN 1258
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Malaria [ICD11: 1F40] | Approved | [1] | |||
| Therapeutic Class |
Antimalarials
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C18H26ClN3O
|
|||||
| Canonical SMILES |
CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
|
|||||
| InChI |
InChI=1S/C18H26ClN3O/c1-3-22(11-12-23)10-4-5-14(2)21-17-8-9-20-18-13-15(19)6-7-16(17)18/h6-9,13-14,23H,3-5,10-12H2,1-2H3,(H,20,21)
|
|||||
| InChIKey |
XXSMGPRMXLTPCZ-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 118-42-3
|
|||||
| Pharmaceutical Properties | Molecular Weight | 335.9 | Topological Polar Surface Area | 48.4 | ||
| Heavy Atom Count | 23 | Rotatable Bond Count | 9 | |||
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 4 | |||
| XLogP |
3.6
|
|||||
| PubChem CID | ||||||
| PubChem SID |
103566848
, 104304133
, 10505161
, 11336117
, 11361356
, 11462328
, 11484852
, 11489054
, 118262645
, 124573764
, 126687853
, 129756062
, 134338155
, 134973873
, 135702786
, 136890426
, 137083308
, 143201344
, 143401603
, 14777730
, 160964848
, 162180925
, 163835395
, 163836798
, 165716210
, 172829147
, 174006176
, 175607648
, 177748295
, 178103773
, 179039315
, 29215442
, 29222777
, 3140459
, 46508459
, 47662363
, 47885484
, 48416094
, 49967663
, 5137975
, 57321921
, 597669
, 75004190
, 7979547
, 8150104
, 8152307
, 85286187
, 9255
, 96024743
, 99302030
|
|||||
| ChEBI ID |
ChEBI:5801
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | BCRP | Transporter Info | Breast cancer resistance protein | Substrate | [2] | |
| References | ||||||
| 1 | Hydroxychloroquine was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | MDR-ABC transporters: biomarkers in rheumatoid arthritis. Clin Exp Rheumatol. 2013 Sep-Oct;31(5):779-87. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.